Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family

Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis.

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.

Peripheral cannabinoid receptor, CB2, regulates bone mass.

Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health.

Cannabinoid receptors and the regulation of bone mass.

Endocannabinoids and the regulation of bone metabolism.

The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption.

The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy.

Cannabinoids and the skeleton: From marijuana to reversal of bone loss.

Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells.

Cannabinoids and bone: Friend or foe?

Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies.

Cannabidiol (CBD) is a cannabinoid component from Cannabis sativa that does not induce psychotomimetic effects and possess anti-inflammatory properties.